Co-Authors
This is a "connection" page, showing publications co-authored by Xiaolong Qi and Jitao Wang.
Connection Strength
1.890
-
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study. J Hepatol. 2021 08; 75(2):439-441.
Score: 0.942
-
Clinical Characteristics of COVID-19 Patients With Pre-existing Hepatitis B Virus Infection: A Multicenter Report. Am J Gastroenterol. 2021 02 01; 116(2):420-421.
Score: 0.232
-
Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China. Hepatol Int. 2020 Jul; 14(4):478-482.
Score: 0.221
-
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study. Gut. 2021 02; 70(2):433-436.
Score: 0.221
-
Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury. J Hepatol. 2020 08; 73(2):455-458.
Score: 0.219
-
Clinical characteristics of coronavirus disease 2019 in Gansu province, China. Ann Palliat Med. 2020 Jul; 9(4):1404-1412.
Score: 0.056